Product Information

LOXAPINE 5 MG CAPSULE is a generic product labeled by Chartwell RX LLC, priced at $0.2979 per EA under NDC 62135049260. Its NADAC has been published 167 times since Jun 14, 2023.

FDA first approved this application on Sep 26, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the Loxapine market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LOXAPINE 5 MG CAPSULE

Loxapine
$0.2979per EA
Low Outlier

Strength

5 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135049260

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LOXAPINE SUCCINATE

Approval Type

Generic (ANDA)

FDA Application

ANDA090695

FDA Approved

9/26/2011

TE Code

AB

On Market Since

9/26/2011

Price Statistics

The NADAC for LOXAPINE 5 MG CAPSULE has been published 167 times since Jun 14, 2023, and over the history we have for it it has declined 40.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2979 per EA
All-time high$0.5044 (Dec 13, 2023)
All-time low$0.2375 (Jan 22, 2025)
52-week high$0.4135
52-week low$0.2949
Median price$0.3169
Average price$0.3511
Largest weekly change-23.5% (Dec 20, 2023)
Weeks tracked167
Tracking sinceJun 14, 2023

Price History

1W

-2.5%

1M

-2.5%

3M

-1.5%

6M

-5.8%

1Y

-28.0%

3Y

-40.9%

5Y

N/A

All

-40.9%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of LOXAPINE 5 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for LOXAPINE 5 MG CAPSULE, manufactured by Chartwell RX LLC, is $0.2979 per EA (NDC 62135049260), effective Aug 19, 2026.

How has the price of LOXAPINE 5 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for LOXAPINE 5 MG CAPSULE has declined 40.9%. It has been tracked across 167 weekly CMS publications since Jun 14, 2023.

What are the highest and lowest recorded NADAC prices for LOXAPINE 5 MG CAPSULE?

Since Jun 14, 2023, the NADAC for LOXAPINE 5 MG CAPSULE has ranged from a low of $0.2375 (Jan 22, 2025) to a high of $0.5044 (Dec 13, 2023), with a median of $0.3169 per EA.

Are there cheaper alternatives to LOXAPINE 5 MG CAPSULE?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LOXAPINE 5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures LOXAPINE 5 MG CAPSULE?

LOXAPINE 5 MG CAPSULE (NDC 62135049260) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.